中国组织工程研究与临床康复
中國組織工程研究與臨床康複
중국조직공정연구여림상강복
JOURNAL OF CLINICAL REHABILITATIVE TISSUE ENGINEERING RESEARCH
2009年
31期
6197-6200
,共4页
戴维德%范智慧%陈敏华%河福金%李洪民%刘静贤
戴維德%範智慧%陳敏華%河福金%李洪民%劉靜賢
대유덕%범지혜%진민화%하복금%리홍민%류정현
射频消融%大鼠%单个核细胞
射頻消融%大鼠%單箇覈細胞
사빈소융%대서%단개핵세포
背景:既往已有研究证实经皮射频消融在有效灭活肿瘤的同时,能够在一定程度上改善机体免疫抑制状态.抗原呈递细胞在机体的抗肿瘤免疫中发挥着重要的作用,树突状细胞是目前所知机体内功能最强的专职性抗原提呈细胞.目的:观察肝脏射频消融后大鼠外周血单个核细胞OX-62,OX-6和CD86的表达变化.设计、时间及地点:随机对照动物实验,于2005-06/2006-03在北京大学临床肿瘤学院完成.材料:选用SD大鼠12只,按随机数字表法分为2组,对照组和射频后1周组各6只.方法:对照组大鼠处死后抽取外周血2 mL.将射频后1周组大鼠肝脏左叶牵出,斜置电极针入肝,展开电极针,射频作用时间4 min.射频完毕给予抗感染治疗,射频治疗后1周处死后抽取外周血.主要观察指标:①正常鼠肝射频后大体和病理学改变.②射频前后外周血内单个核细胞OX-62,OX-6以及CD86表达水平.结果:鼠肝组织射频灶病理组织学检查显示从中心到外围呈凝固性坏死-细胞变性-肉芽组织形成的演变特点.射频后1周组大鼠外周血单个核细胞中树突状细胞特异性标志OX-62的阳性表达率为(0.70±0.16)%,显著高于对照组[(0.34±0.081)%,P<0.05].2组大鼠外周血树突状细胞中OX-6,CD86的阳性表达率差异无显著性意义(P>0.05).结论:射频消融可促进大鼠外周血中树突状细胞前体细胞数量增多,可能会对提高机体在免疫应答中的抗原提呈能力起到促进作用.
揹景:既往已有研究證實經皮射頻消融在有效滅活腫瘤的同時,能夠在一定程度上改善機體免疫抑製狀態.抗原呈遞細胞在機體的抗腫瘤免疫中髮揮著重要的作用,樹突狀細胞是目前所知機體內功能最彊的專職性抗原提呈細胞.目的:觀察肝髒射頻消融後大鼠外週血單箇覈細胞OX-62,OX-6和CD86的錶達變化.設計、時間及地點:隨機對照動物實驗,于2005-06/2006-03在北京大學臨床腫瘤學院完成.材料:選用SD大鼠12隻,按隨機數字錶法分為2組,對照組和射頻後1週組各6隻.方法:對照組大鼠處死後抽取外週血2 mL.將射頻後1週組大鼠肝髒左葉牽齣,斜置電極針入肝,展開電極針,射頻作用時間4 min.射頻完畢給予抗感染治療,射頻治療後1週處死後抽取外週血.主要觀察指標:①正常鼠肝射頻後大體和病理學改變.②射頻前後外週血內單箇覈細胞OX-62,OX-6以及CD86錶達水平.結果:鼠肝組織射頻竈病理組織學檢查顯示從中心到外圍呈凝固性壞死-細胞變性-肉芽組織形成的縯變特點.射頻後1週組大鼠外週血單箇覈細胞中樹突狀細胞特異性標誌OX-62的暘性錶達率為(0.70±0.16)%,顯著高于對照組[(0.34±0.081)%,P<0.05].2組大鼠外週血樹突狀細胞中OX-6,CD86的暘性錶達率差異無顯著性意義(P>0.05).結論:射頻消融可促進大鼠外週血中樹突狀細胞前體細胞數量增多,可能會對提高機體在免疫應答中的抗原提呈能力起到促進作用.
배경:기왕이유연구증실경피사빈소융재유효멸활종류적동시,능구재일정정도상개선궤체면역억제상태.항원정체세포재궤체적항종류면역중발휘착중요적작용,수돌상세포시목전소지궤체내공능최강적전직성항원제정세포.목적:관찰간장사빈소융후대서외주혈단개핵세포OX-62,OX-6화CD86적표체변화.설계、시간급지점:수궤대조동물실험,우2005-06/2006-03재북경대학림상종류학원완성.재료:선용SD대서12지,안수궤수자표법분위2조,대조조화사빈후1주조각6지.방법:대조조대서처사후추취외주혈2 mL.장사빈후1주조대서간장좌협견출,사치전겁침입간,전개전겁침,사빈작용시간4 min.사빈완필급여항감염치료,사빈치료후1주처사후추취외주혈.주요관찰지표:①정상서간사빈후대체화병이학개변.②사빈전후외주혈내단개핵세포OX-62,OX-6이급CD86표체수평.결과:서간조직사빈조병리조직학검사현시종중심도외위정응고성배사-세포변성-육아조직형성적연변특점.사빈후1주조대서외주혈단개핵세포중수돌상세포특이성표지OX-62적양성표체솔위(0.70±0.16)%,현저고우대조조[(0.34±0.081)%,P<0.05].2조대서외주혈수돌상세포중OX-6,CD86적양성표체솔차이무현저성의의(P>0.05).결론:사빈소융가촉진대서외주혈중수돌상세포전체세포수량증다,가능회대제고궤체재면역응답중적항원제정능력기도촉진작용.
BACKROUND:Previous studies have confirmed that radiofrequency ablation(RFA)has not only efficiently killed tumor cells,but also improved immune suppression of organism.Antigen presenting cells play an important role during anti-tumor immune reaction.Dendritic cells are most powerful antigen presenting cells.OBJECTIVE:To study the influence of RFA on OX-62,OX-6 and CD86 expression of rat peripheral blood mononuclear cells.DESIGN,TIME AND SETTING:The randomized controlled animal observation was performed at the School of Oncology of Peking University from June 2005 to March 2006.MATERIALS:A total of 12 Sprague Dawley rats were equally and randomly assigned into control and 1 -week radiofrequency groups.METHODS:2 mL peripheral blood was extracted from rats of the control group following rats were sacrificed.The left lobe of rat liver was exposed,inserted with acicular electrodes at tilted position.The acicular electrodes were spread out.The action time was 4 minutes.After RFA,the rats were given anti-infective therapy.2 mL peripheral blood was taken out after they were put to death 1 week after RFA.MAIN OUTCOME MEASURES:The following parameters were measured:pathomorphological observation on the liver of normal rats after RFA;OX-62,OX-6 and CD86 expression of peripheral blood mononuclear cells before and after RFA.RESULTS:Pathologyical examination after RFA showed the characteristic that coagulation necrosis and cellular degeneration and granulation tissue forming appeared from target center to peripheral of the target.Positive expression rate of OX-62 in rat peripheral blood in the 1-week radiofrequency group[(0.70±0.16)%]was significantly higher than in the control group [(0.34±0.08)%,P <0.05].No significant difference in positive expression rate of OX-6 and CD86 in the peripheral blood mononuclear cells between both groups(P>0.05).CONCLUSION:RFA can promote the increased number of precursor Dendritic cells in rat peripheral blood,which may be contributed to improve the ability to angtigen presentation during immune response.Dai Wei-de,Doctor,Associate chief physician,Department of Ultrasound,Beijing Hospital of Ministry of Public Health,Beijing 100730,China dai.weide@126.com